Do patents prevent access to drugs for HIV in developing countries?

Marleen Boelaert, Lut Lynen, Wim van Damme, Robert Colebunders, Eric Goemaere, Anne Valerie Kaninda, Laura Ciaffi, Maryline Mulemba, Ellen ’T Hoen, Bernard Pécoul, Michael J. Selgelid, Udo Schuklenk, Amir Attaran, Lee Gillespie-White

Research output: Contribution to journalLetterResearchpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)840-843
Number of pages4
JournalJournal of the American Medical Association
Issue number7
Publication statusPublished - 20 Feb 2002
Externally publishedYes


  • Africa
  • Antihiv agents
  • Antiretroviral therapy, highly active
  • Costs and cost analysis
  • Developing countries
  • Drug costs
  • Drug industry
  • Highly active antiretroviral therapy
  • HIV infections
  • Patents

Cite this